WFDC2 and ductal breast carcinoma in situ: In early-stage disease, such as DCIS, HE4 may be involved in local regulatory or differentiation pathways associated with favorable tumor behavior, whereas in more advanced cancers, its overexpression may reflect or contribute to tumor aggressiveness.